Chemoembolization for hepatocellular carcinoma - What, when, and for whom?

被引:13
作者
Lehnert, T
Herfarth, C
机构
关键词
ARTERIAL CHEMOEMBOLIZATION; RANDOMIZED TRIAL;
D O I
10.1097/00000658-199607000-00001
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 14 条
[1]   PRIMARY-TREATMENT OF HEPATOCELLULAR-CARCINOMA BY ARTERIAL CHEMOEMBOLIZATION [J].
BISMUTH, H ;
MORINO, M ;
SHERLOCK, D ;
CASTAING, D ;
MIGLIETTA, C ;
CAUQUIL, P ;
ROCHE, A .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (04) :387-394
[2]   RESULTS OF TREATMENT OF PATIENTS WITH HEPATOCELLULAR-CARCINOMA WITH SEVERE CIRRHOSIS OF THE LIVER [J].
FUJIO, N ;
SAKAI, K ;
KINOSHITA, H ;
HIROHASHI, K ;
KUBO, S ;
IWASA, R ;
LEE, KC .
WORLD JOURNAL OF SURGERY, 1989, 13 (02) :211-218
[3]   Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? [J].
Harada, T ;
Matsuo, K ;
Inoue, T ;
Tamesue, S ;
Inoue, T ;
Nakamura, H .
ANNALS OF SURGERY, 1996, 224 (01) :4-9
[4]  
KOO J, 1983, CANCER-AM CANCER SOC, V52, P1952, DOI 10.1002/1097-0142(19831115)52:10<1952::AID-CNCR2820521029>3.0.CO
[5]  
2-0
[6]   THERAPEUTIC MODALITIES AND PROGNOSTIC FACTORS FOR PRIMARY AND SECONDARY LIVER-TUMORS [J].
LEHNERT, T ;
OTTO, G ;
HERFARTH, C .
WORLD JOURNAL OF SURGERY, 1995, 19 (02) :252-263
[7]   HEPATIC ARTERIAL EMBOLIZATION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA - A RANDOMIZED CONTROLLED TRIAL [J].
LIN, DY ;
LIAW, YF ;
LEE, TY ;
LAI, CM .
GASTROENTEROLOGY, 1988, 94 (02) :453-456
[8]   RANDOMIZED TRIAL OF TARGETED CHEMOTHERAPY WITH LIPIODOL AND 5-EPIDOXORUBICIN COMPARED WITH SYMPTOMATIC TREATMENT FOR HEPATOMA [J].
MADDEN, MV ;
KRIGE, JEJ ;
BAILEY, S ;
BENINGFIELD, SJ ;
GEDDES, C ;
WERNER, ID ;
TERBLANCHE, J .
GUT, 1993, 34 (11) :1598-1600
[9]   A RANDOMIZED TRIAL OF HEPATIC ARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA [J].
PELLETIER, G ;
ROCHE, A ;
INK, O ;
ANCIAUX, ML ;
DERHY, S ;
ROUGIER, P ;
LENOIR, C ;
ATTALI, P ;
ETIENNE, JP .
JOURNAL OF HEPATOLOGY, 1990, 11 (02) :181-184
[10]  
RAOUL JL, 1994, J NUCL MED, V35, P1782